INCOME TAXES - Additional Tax Disclosures (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Taxes
Accrued interest and penalties	$ 0	$ 0
Uncertain Tax Positions
Unrecognized tax benefits	19,443	16,324	$ 14,872	$ 15,185
Net decrease in tax portions			$ (313)
Net increase in tax portions	3,119	$ 1,452
Entasis Therapeutics Holdings Inc
Income Taxes
Federal net operating losses estimated utilization amount	155,600
La Jolla Pharmaceutical Company
Income Taxes
Federal net operating losses estimated utilization amount	309,500
Federal
Income Taxes
Net operating loss carryforwards	543,500
State
Income Taxes
Net operating loss carryforwards	1,000,000
State | Research and development
Income Taxes
Tax credit carryforward amount	$ 33,300